罕见病药物氨己烯酸片治疗什么病呢

What diseases do rare disease drugs treat?

Vigabatrin tablets (vigabatrin) can be used to assist in the treatment of refractory complex epilepsy with partial seizures and tardive dyskinesia. Vigabatrin tablets (vigabatrin) can also be used to treat infantile spasms and Lennox-Gastaut syndrome.

Vigabatrin is used in tardive dyskinesia. It has anti-epileptic effects, and its mechanism of action is to irreversibly inhibit GABA aminotransferase (GABA-T) and increase the concentration of GABA in the brain to exert its effects. Clinical study results indicate that vigabatrin is used in tardive dyskinesia. It is an effective and safe anti-epileptic drug for treating children with severe epilepsy, and is also effective for epilepsy patients with intellectual disabilities.

Vigabatrin tablets (vigabatrin) have significant therapeutic effects, but taking this drug for treatment will also produce certain side effects or adverse reactions. Common ones include: fatigue/drowsiness/headache/dizziness/mental confusion/depression, etc. Before receiving treatment with vigabatrin, patients should go to the hospital for detailed testing and take medication strictly according to the doctor's diagnosis and treatment recommendations. The use of vigabatrin tablets (vigabatrin) should be done under the guidance of an epilepsy expert or a child neurologist. Reactions after taking the medication should be reported to the doctor promptly.

The number of surveyable data on vigabatrin during pregnancy was limited (192 cases). 14.5% of those taking Vigabatrin during pregnancy had congenital anomalies. Among them, 64.3% were major deformities. Spontaneous miscarriage occurs in 10.9% of women taking vigabatrin tablets during pregnancy.

Due to limited clinical reporting data on epilepsy and concomitant use of antiepileptic drugs, we cannot definitively conclude whether vigabatrin increases the risk of malformations during pregnancy. There are no data indicating that children may develop visual field defects in utero while taking vigabatrin. Reproductive toxicity has emerged in experimental studies in animals. These relevant data are not yet known for humans.

The above is the introduction about (vigabatrin), I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/82944.html